New York State Common Retirement Fund Buys 59,451 Shares of HealthEquity, Inc. (NASDAQ:HQY)

New York State Common Retirement Fund boosted its position in HealthEquity, Inc. (NASDAQ:HQYFree Report) by 131.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 104,809 shares of the company’s stock after purchasing an additional 59,451 shares during the quarter. New York State Common Retirement Fund owned about 0.12% of HealthEquity worth $7,656,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Norges Bank bought a new position in shares of HealthEquity in the 4th quarter worth $34,071,000. Clearbridge Investments LLC grew its holdings in shares of HealthEquity by 23.5% during the 2nd quarter. Clearbridge Investments LLC now owns 1,966,559 shares of the company’s stock valued at $124,169,000 after purchasing an additional 374,129 shares during the last quarter. BlackRock Inc. grew its holdings in shares of HealthEquity by 4.0% during the 1st quarter. BlackRock Inc. now owns 9,423,008 shares of the company’s stock valued at $635,488,000 after purchasing an additional 358,743 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of HealthEquity by 15.5% during the 1st quarter. JPMorgan Chase & Co. now owns 2,474,430 shares of the company’s stock valued at $145,273,000 after purchasing an additional 331,735 shares during the last quarter. Finally, Franklin Resources Inc. grew its holdings in shares of HealthEquity by 23.4% during the 2nd quarter. Franklin Resources Inc. now owns 1,445,385 shares of the company’s stock valued at $91,262,000 after purchasing an additional 274,268 shares during the last quarter. 98.46% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on HQY. Raymond James increased their target price on shares of HealthEquity from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 13th. Barrington Research reaffirmed an “outperform” rating and set a $85.00 target price on shares of HealthEquity in a report on Monday, December 4th. Barclays assumed coverage on shares of HealthEquity in a report on Wednesday, January 3rd. They issued an “overweight” rating and a $84.00 price target on the stock. Wells Fargo & Company raised their price target on shares of HealthEquity from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 6th. Finally, JPMorgan Chase & Co. cut their price target on shares of HealthEquity from $81.00 to $73.00 and set an “overweight” rating on the stock in a report on Friday, December 1st. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $83.25.

View Our Latest Report on HQY

HealthEquity Trading Up 2.0 %

NASDAQ:HQY opened at $79.61 on Friday. The company has a 50-day moving average price of $70.92 and a 200-day moving average price of $69.98. HealthEquity, Inc. has a 12 month low of $48.86 and a 12 month high of $80.22. The company has a current ratio of 4.93, a quick ratio of 4.93 and a debt-to-equity ratio of 0.44. The stock has a market cap of $6.83 billion, a price-to-earnings ratio of 234.15, a P/E/G ratio of 1.30 and a beta of 0.55.

HealthEquity (NASDAQ:HQYGet Free Report) last posted its earnings results on Tuesday, December 5th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.32 by $0.08. HealthEquity had a net margin of 3.00% and a return on equity of 5.89%. The firm had revenue of $249.22 million during the quarter, compared to analysts’ expectations of $243.63 million. Equities analysts predict that HealthEquity, Inc. will post 1.48 EPS for the current year.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 2,499 shares of HealthEquity stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the transaction, the executive vice president now directly owns 49,996 shares of the company’s stock, valued at approximately $3,999,680. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, EVP Elimelech Rosner sold 2,017 shares of HealthEquity stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $70.09, for a total transaction of $141,371.53. Following the completion of the transaction, the executive vice president now directly owns 62,898 shares of the company’s stock, valued at approximately $4,408,520.82. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Delano Ladd sold 2,499 shares of HealthEquity stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the transaction, the executive vice president now directly owns 49,996 shares of the company’s stock, valued at $3,999,680. The disclosure for this sale can be found here. In the last ninety days, insiders sold 52,102 shares of company stock valued at $3,379,812. Company insiders own 2.70% of the company’s stock.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.